Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression
Status:
Withdrawn
Trial end date:
2017-04-30
Target enrollment:
Participant gender:
Summary
This research is aimed to investigate the efficacy and safety of the creatine and cytidine
augmentation in treating bipolar depression and to evaluate changes in relevant brain
biochemical metabolism using proton and phosphorous magnetic resonance spectroscopy.